In one paragraphArticle in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Gabriel Augusto Pires de SouzaVirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3001 Leuven, Belgium.ORCID 0000-0002-2479-4429 Rana AbdelnabiVirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3001 Leuven, Belgium.ORCID 0000-0001-9771-7312 Bert VanmechelenVirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3001 Leuven, Belgium.ORCID 0000-0002-8350-4356 Leni Van EyckVirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3001 Leuven, Belgium.
Nelleke CloetVirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3001 Leuven, Belgium.
Deniz ÖnerVirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3001 Leuven, Belgium.
Dirk RoymansVirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3001 Leuven, Belgium.
Aleksandra SiekierskaVirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3001 Leuven, Belgium.ORCID 0000-0003-4907-605X Koert StittelaarVirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3001 Leuven, Belgium.ORCID 0000-0002-0607-3214 Johan NeytsVirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3001 Leuven, Belgium.ORCID 0000-0002-0033-7514 Funding
This work was supported by the Belgian Federal Government for the VirusBank Platform (FOD VVVL) NA
6 · The paper itselfAbstract
The re-emergence of alphaviruses (family
Indexed as
AlphavirusAntiviral AgentsHigh-Throughput Screening AssaysSindbis VirusVirus ReplicationAlphavirus InfectionsAnimalsCell LineChikungunya virusDrug DiscoveryDrug Evaluation, PreclinicalGenes, ReporterGreen Fluorescent ProteinsHumansReproducibility of ResultsAntiviral AgentsGreen Fluorescent Proteinsalphavirusantiviral screeningchikungunya virusemerging viruseshigh-throughput screeningSindbis virus
Identifiers
PMID41902198
PMCPMC13030731
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390